We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.

Autor: Atujuna M; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Cape Town, South Africa., Williams K; RTI International, Research Triangle Park, NC, United States of America., Roberts ST; RTI International, Research Triangle Park, NC, United States of America., Young A; RTI International, Research Triangle Park, NC, United States of America., Browne EN; RTI International, Research Triangle Park, NC, United States of America., Mangxilana NT; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, Cape Town, South Africa., Tenza S; WITS Reproductive Health and HIV Institute (WRHI), Johannesburg, South Africa., Shapley-Quinn MK; RTI International, Research Triangle Park, NC, United States of America., Tauya T; University of Zimbabwe Clinical Trials Research Centre (UZ-CRC), Harare, Zimbabwe., Ngure K; School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, WA, United States of America., van der Straten A; Dept of Medicine, Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA, United States of America.; ASTRA consulting, Kensington, CA, United States of America.

Publikováno v: PloS one [PLoS One] 2024 Aug 29; Vol. 19 (8), pp. e0308577. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).